Shruti Bhatt

Assistant Professor

Singapore

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shruti Bhatt is an Assistant Professor at the National University of Singapore. Her research focuses on hematologic malignancies, particularly acute myeloid leukemia and the role of T cell receptors in cancer therapy. Dr. Bhatt has contributed to various studies addressing mechanisms of drug resistance and tumor immunology, with recent publications exploring topics such as TP53 mutations and apoptotic priming in leukemia. Her work aims to enhance therapeutic strategies and functional profiling in cancer treatment.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Melissa Ooi

Assistant Professor of Medicine

National University of Singapore (NUS)

SINGAPORE

View details

Felipe Beckedorff

Research Assistant Professor

University of Miami School of Medicine

UNITED STATES

View details

Benjamin Ebert

Dana-Farber Cancer Institute

UNITED STATES

View details

Samuel Myers

Broad Institute

UNITED STATES

View details

Skye Montoya

Yale University

UNITED STATES

View details

Anna Marneth

Assistant Professor

Radboudumc

NETHERLANDS

View details

Elyse A. Olesinski

Harvard University

UNITED STATES

View details

Jana Ellegast

Assistant Professor for Translational Oncology; Attending Physician

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shruti Bhatt

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Protocol for the simultaneous activation and lentiviral transduction of primary human T cells with artificial T cell receptors

The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies

Mitochondria and Acute Leukemia: A Clinician’s Perspective

TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications

Decoding Acute Myeloid Leukemia: A Clinician’s Guide to Functional Profiling

Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition.

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.

Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches.

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy.

BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia.

CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response

Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.

Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse models.

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia.

Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re‐induction chemotherapy

Collaborators (8)

Melissa Ooi

Felipe Beckedorff

Benjamin Ebert

Samuel Myers

Skye Montoya

Anna Marneth

Elyse A. Olesinski

Jana Ellegast

Make your next move.